Dr. Goldfischer highlights the value of PSMA-PET imaging in urology

“PSMA scanning is definitely a game-changer with regard to imaging in advanced prostate cancer in urology,” says Evan R. Goldfischer, MD.

In this interview, Evan R. Goldfischer, MD, MBA, FACS, discusses the value of PSMA-PET imaging in prostate cancer. Goldfischer chaired a discussion on the rapidly emeging modalitiy during the 2022 LUGPA Annual Meeting in Chicago, Illinois. Goldfischer is the director of the Research Department at Premier Medical Group in Poughkeepsie, New York, and new LUGPA president.

Related Videos
Benjamin Lowentritt, MD, FACS, in an interview with Urology Times
Related Content
© 2023 MJH Life Sciences

All rights reserved.